Position in ANAB
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$40,735,507
+$5,343,130 QoQ
Shares Held
603,489
-37.0% QoQ
Ownership
2.07%
of shares outstanding
% of Portfolio
5.63%
of 13F equity value
Holder Rank
#12
of 211 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Palo Alto Investors LP holds $594,195,112 across 39 Biotechnology names. ANAB ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
918,846 | $74,950,268 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
2,864,096 | $72,461,628 | |
| 3 | INSM |
INSMED Inc
|
413,980 | $44,138,547 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
348,808 | $40,834,952 | |
| 5 | ANAB |
Anaptysbio, Inc
This page
|
603,489 | $40,735,507 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
682,777 | $39,068,499 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
1,647,521 | $36,591,441 | |
| 8 | IRON |
Disc Medicine, Inc.
|
416,646 | $30,473,488 |
All Filings in ANAB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,735,507 | 603,489 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $35,392,377 | 638,161 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $33,452,751 | 690,032 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,623,148 | 673,520 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,044,626 | 812,821 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,975,003 | 1,020,713 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,174,218 | 843,971 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,272,986 | 843,971 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $20,139,283 | 803,641 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,013,843 | 799,906 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,713,012 | 686,882 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $7,744,761 | 431,224 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,771,096 | 431,224 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,383,455 | 431,224 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,357,433 | 431,024 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,995,443 | 431,024 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,749,765 | 431,024 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,663,512 | 431,024 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $15,171,593 | 436,592 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,840,375 | 436,592 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,320,852 | 436,592 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,408,579 | 436,592 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,950,257 | 416,292 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,438,631 | 368,722 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||